• STAT Plus: The cost of Gilead's HIV prevention pill thwarted widespread use, study finds

    14 days ago - By STAT

    The escalating cost of the only HIV prevention pill may have been a key factor hindering widespread use in recent years, according to a new analysis by U.S. government researchers, underscoring long-standing concerns over the ability to eradicate the virus.
    From 2014 to 2018, total payments made by government programs, commercial insurers, and patients for Truvada, which was approved to prevent HIV in 2012, jumped from $114 million to nearly $2.1 billion. Yet the number of people who were given prescriptions in 2018 was just 204,700, which amounted to less than 20% of those estimated to...
    Read more ...

     

  • STAT Plus: In research on pigs, scientists test a new way to boost recovery after a heart attack

    14 days ago - By STAT

    Scientists have developed a new strategy that uses exosomes - tiny, RNA-loaded packets that cells spit out - to regenerate cardiac cells after damage from a heart attack.
    The heart muscles are made of specialized cells that work continuously to pump blood to our entire body. When one of the heart's blood vessels gets blocked, it can cause a heart attack, which often leads to tissue damage and scars. Scientists have previously explored whether cell transplants could speed recovery after heart attacks, but the cells often failed to graft, and experts worried about the health risks of such a...
    Read more ...